GSK180736A

    • Catalog No.:MC1382
    • Description
    • CasNo:
    • 817194-38-0
    • MolecularFormula:
    • C19H16FN5O2
    • Purity:
    • >98%
    • Target:
    • ROCK
    • IC50:
    • IC50: 0.77 μM (GRK2), 100 nM (ROCK1)[1]
    • In Vitro:
    • GSK180736A is a compound structurally similar to paroxetine that is developed as a ROCK inhibitor, i
    • Fields:
    • GSK180736A is a G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 0.77 μM.
    • Specificity:
    • Target: ROCK. Fields: GSK180736A is a G protein-coupled receptor kinase 2 (GRK2) inhibitor with an IC50 of 0.77 μM.
    • Dilution:
    • IC50: 0.77 μM (GRK2), 100 nM (ROCK1)[1]
    • Concentration:
    • >98%
    • Storage Stability:
    • 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO
    • Other Name:
    • GSK 180736A; GSK-180736A
    • MolecularWeight(Da):
    • 365.36
    • Products Images